Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

$DMACPress releaseJul 17, 2026, 4:30 PM ETRead the release

DiaMedica granted 160,000 stock options to a new non-executive employee as an employment inducement under Nasdaq Rule 5635(c)(4). The options have an exercise price of $7.64 per share, equal to the closing price on the grant date, and vest over a four-year period beginning one year from the grant date.

Key figures

Option shares
160000
Exercise price
7.64

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    DMAC: DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — AI Analysis | Signal8